Global deep brain stimulator market: 17% CAGR between 2012-2016

The Global Deep Brain Stimulator market is to grow at a CAGR of 16.99 percent over the period 2012-2016. One of the key factors contributing to this market growth is the rapidly increasing awareness about deep brain stimulation devices in the US. The Global Deep Brain Stimulator market has also been witnessing the emergence of less invasive and non-invasive treatments. However, the high cost of deep brain stimulation treatment could pose a challenge to the growth of this market.

There is a general perception that DBS treatments are risky since they involve surgery to implant electrodes in the brain. Hence, less invasive and non-invasive DBS treatments are gaining greater acceptance from doctors and surgeons in the Healthcare industry. New lines of research in the R and D sector are enabling surgeons and healthcare specialists to carry out more selective stimulation. For instance, selective stimulation is used with respect to the innervation of the urinary bladder at peripheral sites (such as pudendal nerve stimulation) with the use of less invasive devices such as Bion and other implantable devices. Thus, the adoption of alternative treatments that are less invasive is seen to be an emerging trend during the forecast period.

One of the key drivers in this market is that DBS therapy is considered to be the standard form of care for many diseases and conditions such as epilepsy, depression, stroke, anxiety disorders, and Parkinson’s disease. Hence, this market is expected to grow at a rapid pace and achieve a similar market size to the Global Cardiac Devices market.

One of the major challenges in the market is the high cost of deep brain stimulation treatments and therapies. The high cost has rendered deep brain stimulation treatments and therapies unaffordable for patients in developing nations.

For more information on the Global deep brain stimulator market, please click here: Global deep brain stimulator market